相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Metabolic dysregulation and emerging therapeutical targets for hepatocellular carcinoma
Danyu Du et al.
ACTA PHARMACEUTICA SINICA B (2022)
Hepatocellular carcinoma
Josep M. Llovet et al.
NATURE REVIEWS DISEASE PRIMERS (2021)
Identification and Validation of a Nine-Gene Amino Acid Metabolism-Related Risk Signature in HCC
Yajuan Zhao et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)
The microenvironmental and metabolic aspects of sorafenib resistance in hepatocellular carcinoma
Shunjie Xia et al.
EBIOMEDICINE (2020)
Integrated analysis reveals critical glycolytic regulators in hepatocellular carcinoma
Chenying Lu et al.
CELL COMMUNICATION AND SIGNALING (2020)
Sorafenib Resistance in Hepatocellular Carcinoma: The Relevance of Genetic Heterogeneity
Loraine Kay D. Cabral et al.
CANCERS (2020)
Emerging roles and the regulation of aerobic glycolysis in hepatocellular carcinoma
Jiao Feng et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2020)
The miR-30a-5p/CLCF1 axis regulates sorafenib resistance and aerobic glycolysis in hepatocellular carcinoma
Zhongqiang Zhang et al.
CELL DEATH & DISEASE (2020)
Modified parylene-N films as chemical microenvironments for differentiation and spheroid formation of osteoblast cells
Tae-Hun Kim et al.
SCIENTIFIC REPORTS (2020)
A powerful drug combination strategy targeting glutamine addiction for the treatment of human liver cancer
Haojie Jin et al.
ELIFE (2020)
Mitochondrial UQCC3 Modulates Hypoxia Adaptation by Orchestrating OXPHOS and Glycolysis in Hepatocellular Carcinoma
Yun Yang et al.
CELL REPORTS (2020)
The mechanisms of sorafenib resistance in hepatocellular carcinoma: theoretical basis and therapeutic aspects
Weiwei Tang et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
Histidine Metabolism and Function
Margaret E. Brosnan et al.
JOURNAL OF NUTRITION (2020)
AASLD guidelines for the treatment of hepatocellular carcinoma
Julie K. Heimbach et al.
HEPATOLOGY (2018)
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
Peter R. Galle et al.
JOURNAL OF HEPATOLOGY (2018)
The Human SLC7A5 (LAT1): The Intriguing Histidine/Large Neutral Amino Acid Transporter and Its Relevance to Human Health
Mariafrancesca Scalise et al.
FRONTIERS IN CHEMISTRY (2018)
Histidine catabolism is a major determinant of methotrexate sensitivity
Naama Kanarek et al.
NATURE (2018)
Aberrant Metabolism in Hepatocellular Carcinoma Provides Diagnostic and Therapeutic Opportunities
Serena De Matteis et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2018)
Sorafenib resistance in hepatocarcinoma: role of hypoxia-inducible factors
Carolina Mendez-Blanco et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2018)
Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update
Masao Omata et al.
HEPATOLOGY INTERNATIONAL (2017)
PPARδ Reprograms Glutamine Metabolism in Sorafenib-Resistant HCC
Mi-Jin Kim et al.
MOLECULAR CANCER RESEARCH (2017)
18F-Fluorodeoxyglucose uptake on positron emission tomography/computed tomography is associated with metastasis and epithelial-mesenchymal transition in hepatocellular carcinoma
Misu Lee et al.
CLINICAL & EXPERIMENTAL METASTASIS (2017)
New knowledge of the mechanisms of sorafenib resistance in liver cancer
Yan-jing Zhu et al.
ACTA PHARMACOLOGICA SINICA (2017)
Heterogeneity in Cancer Metabolism: New Concepts in an Old Field
Geraldine Gentric et al.
ANTIOXIDANTS & REDOX SIGNALING (2017)
Inhibition of glucose metabolism prevents glycosylation of the glutamine transporter ASCT2 and promotes compensatory LAT1 upregulation in leukemia cells
Florence Polet et al.
ONCOTARGET (2016)
STAT3 is a key transcriptional regulator of cancer stem cell marker CD133 in HCC
Sarani Ghoshal et al.
HEPATOBILIARY SURGERY AND NUTRITION (2016)
Signal transducer and activator of transcription 3-mediated CD133 up-regulation contributes to promotion of hepatocellular carcinoma
Cheolhee Won et al.
HEPATOLOGY (2015)
Serine and glycine metabolism in cancer
Ivano Amelio et al.
TRENDS IN BIOCHEMICAL SCIENCES (2014)
Transcriptome analysis of MENX-associated rat pituitary adenomas identifies novel molecular mechanisms involved in the pathogenesis of human pituitary gonadotroph adenomas
Misu Lee et al.
ACTA NEUROPATHOLOGICA (2013)
Role of sorafenib in the treatment of advanced hepatocellular carcinoma: An update
Angela Gauthier et al.
HEPATOLOGY RESEARCH (2013)
Serum metabolomics reveals the deregulation of fatty acids metabolism in hepatocellular carcinoma and chronic liver diseases
Lina Zhou et al.
ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2012)
Up-regulation of L-Type Amino Acid Transporter 1 (LAT1) in Cultured Rat Retinal Capillary Endothelial Cells in Response to Glucose Deprivation
Ryo Matsuyama et al.
DRUG METABOLISM AND PHARMACOKINETICS (2012)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Protective Effects from Carnosine and Histidine on Acetaminophen-Induced Liver Injury
Sheng-lei Yan et al.
JOURNAL OF FOOD SCIENCE (2009)
Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
Ann-Lii Cheng et al.
LANCET ONCOLOGY (2009)
Sorafenib for the Treatment of Unresectable Hepatocellular Carcinoma
Robert C. Kane et al.
ONCOLOGIST (2009)
Management of hepatoceullular carcinoma
J Bruix et al.
HEPATOLOGY (2005)
分享论文
